使用日本药物不良事件报告数据库对贝瓦西祖马布诱导的胃肠孔隙的分析
Kana Sugishita1, Mika Maezawa1, Koumi Miyasaka1
1Laboratory of Drug Informatics, Gifu Pharmaceutical University, Gifu, JPN.
Cureus
|March 10, 2025
概括
贝瓦西祖马布诱导的胃肠道穿孔 (BIGP) 在非小细胞肺癌患者中比在结直肠或卵巢癌患者中更早发生. 在非小细胞肺癌中早期发现BIGP,可以及时进行干预.
科学领域:
- 在瘤学瘤学.
- 药物监督 药物监督 药物监督
- 临床试验分析
背景情况:
- 贝瓦西祖马布是一种VEGF抑制剂,用于治疗各种癌症.
- 贝瓦西祖马布诱导的胃肠穿孔 (BIGP) 是一种罕见但严重的不良事件.
- 了解BIGP的发病和结果对于患者的安全至关重要.
研究的目的:
- 为了评估贝瓦齐祖马布诱导的胃肠道穿孔 (BIGP) 在不同癌症迹象的发病时间.
- 分析BIGP的结果.
- 评估当贝瓦西祖马布与其他抗癌药物结合使用时BIGP的风险.
主要方法:
- 使用了日本药物不良反应报告 (JADER) 数据库.
- 提取的胃肠道穿孔 (SMQ 20000107) 报告.
- 对组合疗法进行了时间到发病分析,结果评估和关联规则挖掘.
主要成果:
- 从887704份不良事件报告中分析了2,112份BIGP报告.
- 与结直肠癌 (77.0天) 和卵巢癌 (67.0天) 相比,非小细胞肺癌 (46.0天) 的BIGP发病时间明显较早.
- 协会规则挖掘确定了与早期 (1-100天) 和晚期 (101-200天) BIGP发病相关的特定药物组合.
结论:
- 在非小细胞肺癌患者中,BIGP发病的时间显著缩短.
- 这一发现有助于早期发现和干预BIGP.
- 对组合疗法的进一步研究可以完善BIGP的风险评估.
更多相关视频
相关概念视频
Esophageal Perforation-I: Introduction
56
Esophageal perforation is a severe medical condition characterized by a breach in the integrity of the esophageal wall. This breach can occur due to various factors such as trauma, medical procedures, or underlying diseases. When the esophageal wall is compromised, it allows food, fluids, and digestive juices into the chest cavity or adjacent structures, leading to potential complications and health risks.
The location of esophageal perforation can vary, occurring anywhere along the esophagus....
The location of esophageal perforation can vary, occurring anywhere along the esophagus....
56
Esophageal Perforation-II: Clinical Manifestations and Management
31
Esophageal perforations manifest in various clinical forms, influenced by factors such as the perforation's cause and location (cervical, intrathoracic, or intra-abdominal), the extent of contamination, and potential injury to adjacent mediastinal structures. The timing between the perforation occurrence and treatment initiation also affects the clinical presentation.
Clinical Manifestations:
Clinical Manifestations:
31
Drug Absorption: Factors Affecting GI Absorption
3.7K
The process of oral drug absorption can be influenced by several factors. Weakly acidic drugs tend to be absorbed more readily from the stomach due to their nonionized state. However, absorption may be less efficient in the upper intestine, where drugs are often ionized. Interestingly, despite the stomach's apparent advantage for drug absorption, its mucous layer can hinder diffusion. Its surface area is also smaller than the intestine's, which can further slow down the absorption rate.
3.7K
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
448
Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
448
Assessment of the Gastrointestinal System I: Subjective Data
130
Assessing the gastrointestinal (GI) system is a complex process that begins with collecting subjective data. This data, collected through patient interviews, provides crucial insights into the patient's health history, perception patterns, and lifestyle habits, all contributing significantly to GI health.
Health History
The initial step in assessing the GI system is obtaining a comprehensive health history. This includes inquiring about the patient's history or presence of problems...
Health History
The initial step in assessing the GI system is obtaining a comprehensive health history. This includes inquiring about the patient's history or presence of problems...
130
Drug Absorption: Overview
486
The process of drug absorption signifies the transition of a drug from its site of administration into the plasma. This process is influenced by various factors, including the route of administration, the anatomy of the absorption site, the mechanism of absorption, gut motility, and the drug's physicochemical properties.
When drugs are injected intravenously, they directly enter the systemic circulation. Alternatively, orally administered drugs navigate through the gastrointestinal (GI)...
When drugs are injected intravenously, they directly enter the systemic circulation. Alternatively, orally administered drugs navigate through the gastrointestinal (GI)...
486


